Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00603720 · ClinicalTrials.gov registry record · NA
Role of Nitric Oxide in the Impact of Aging on Myocardial Remodeling
A NA study, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- NA
- Development phase
- 54
- Enrollment target
NCT00603720 is a NA study that has completed, run by Washington University School of Medicine. The registered enrollment target is 54 participants.
The verdict
NCT00603720, a NA study, has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- NA
- Development phase
- 54 participants
- Enrollment target
Study Summary
The purpose of this study is to determine, with Positron Emission Tomography (PET), the role of nitric oxide in the age-associated effect on fatty acid and glucose delivery on myocardial substrate metabolism.
Interventions
- DRUG L-Arginine
- DRUG L-NAME
- DRUG Phenylephrine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 54 participants |
| Start Date | 2005-09 |
| Est. Completion | 2008-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00603720
The ClinicalTrials.gov registry entry for NCT00603720 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 54 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which L-Arginine is the first listed.
NCT00603720 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00603720 about?
NCT00603720 is a clinical study titled "Role of Nitric Oxide in the Impact of Aging on Myocardial Remodeling". The purpose of this study is to determine, with Positron Emission Tomography (PET), the role of nitric oxide in the age-associated effect on fatty acid and glucose delivery on myocardial substrate metabolism.
What is the current status of trial NCT00603720?
This trial is currently completed. It is a NA study. The enrollment target is 54 participants. The study started on 2005-09. Estimated completion is 2008-06.
What interventions are being tested in trial NCT00603720?
The interventions under investigation include: L-Arginine (DRUG), L-NAME (DRUG), Phenylephrine (DRUG).
Who is sponsoring clinical trial NCT00603720?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.